Review paper: Burn coverage technologies: Current concepts and future directions

Journal of Biomaterials Applications

Volumn 22, Issue 2, 2007, Pages 101-121

  Pereira, Clifford ^a   Gold, Warren ^b   Herndon, David ^b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; CELL CULTURE; COLLAGEN; FIBROBLASTS; GRAFTS; SKIN; TISSUE;

ALOGENEIC CULTURED DERMAL SUBSTITUTES; EPIDERMAL RECONSTRUCTION; KERATINOCYTES; POLYBENZIMIDAZOLE; POLYETHER AMIDE;

ARTIFICIAL ORGANS;

ARTIFICIAL SKIN; BURN; CLASSIFICATION; EPIDERMIS; HUMAN; REVIEW;

BURNS; EPIDERMIS; HUMANS; SKIN, ARTIFICIAL;

EID: 38449107752     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328207081690     Document Type: Review

References (75)

1. Pereira, C.T., Barrow, R.E., Sterns, A., Jeschke, M., Hawkins, H., Rosanblatt, J., Kimbrough, C., Lee, J., Sanford, A. and Herndon, D.N. (2006). Age-dependent Differences in Survival After Severe Burns: A Unicentric Review of 1674 Patients and 179 Autopsies over 15 Years, J. American Coll. Surg., 202: 536-548.
2. Martin, P. (1997). Wound healing - Aiming for Perfect Skin Regeneration, Science, 276: 75-81.
3. Kanzler, M.H., Gorsulowsky, D.C. and Swanson, N.A. (1986). Basic Mechanisms in the Healing Cutaneous Wound, J. Dermatol. Surg. Oncol., 12: 1156-1164.
4. Heimbach, D.M. (1987). Early Burn Excision and Grafting, Surg. Clin. North Am., 67: 93-107.
5. Sawicki, G., Marcoux, Y., Sarkhosh, K., Tredget, E.E. and Ghahary, A. (2005). Interaction of Keratinocytes and Fibroblasts Modulates the Expression of Matrix Metalloproteinases 2 and 9 and their Inhibitors, Mol. Cell Biochem., 269: 209-216.
6. Atiyeh, B.S., Gunn, S.W. and Hayek, S.N. (2005). State of the Art in Burn Treatment, World J. Surg., 29: 131-148.
7. Rheinwald, J.G. and Green, H. (1975). Serial Cultivation of Strains of Human Epidermal Keratinocytes: The Formation of Keratinizing Colonies from Single Cells, Cell, 6: 331-344.
8. Kaiser, H.W., Stark, G.B. and Kopp, J. (1994) Cultured Autologous Keratinocytes in Fibrin Glue Suspension, Exclusively and Combined with STS-allograft - Preliminary Clinical and Histolocical Report of a New Technique, Burns, 20: 23-29.
9. Pellegrini, G., Ranno, R. and Stracuzzi, G. (1999). The Control of Epidermal Stem Cells in the Treatment of Massive Full Thickness Burns with Autologous Keratinocytes Cultured on Fibrin, Transplantation, 68: 868-879.
10. Prenosil, J.E. and Kino-oka, M. (1999). Computer Controlled Bioreactor for Large Scale Production of Cultured Skin Grafts, Ann. NY Acad. Sci., 875: 386-397.
11. Bannash, H., Fohn, M. and Unterberg, T. (2003). Skin Tissue Engineering, Clin. Plast. Surg., 30: 573-579.
12. Woodley, D.T., Peterson, H.D. and Herzog, S.R. (1988). Burn Wounds Resurfaced by Cultured Epidermal Autografts Show Abnormal Reconstitution of Anchoring Fibrils, JAMA, 259: 2566-2571.
13. Altankov, G., Albrecht, W., Richau, K., Groth, T. and Lendlein, A. (2005). On the Tissue Compatibility of Poly Ether Imide Membranes: An in vitro Study on their Interaction with Human Dermal Fibroblasts and Keratinocytes, J. Biomater. Sci. Polym. Ed., 16: 23-42.
14. Rouabhia, M. (1996). Permanent Skin Replacement using Chimeric Epithelial Cultured Sheets Comprising Xenogeneic and Syngeneic Keratinocytes, Transplantation, 61: 1290-1300.
15. Myers, S.R., Grady, J. and Soranzo, C. (1997). A Hyaluronic Acid Membrane Delivery System for Cultured Keratinocytes: Clinical Take Rates in the Porcine Kerato-dermal Model, J. Burn Care Rehabil., 18: 214-222.
16. Lam, P.K., Chan, E.S.Y., To, E.W.H., Lau, C.H., Yen, S.C. and King, W.W.K. (1999). Development and Evaluation of a New Composite Laserskin Graft, J. Trauma, 47: 918-922.
17. Burke, J.F., Yannas, I.V., Quinby, W.C., Bondoc, C.C. and Jung, W.K. (1981). Successful Use of a Physiologically Acceptable Artificial Skin in the Treatment of Extensive Burn Injury, Ann. Surg., 194: 413-428.
18. Mis, B., Rolland, E. and Ronfard, V. (2004). Combined Use of a Collagen-based Dermal Substitute and a Fibrin-based Cultured Epithelium: A Step Toward a Total Skin Replacement for Acute Wounds, Burns, 30: 713-719.
19. Oka, H., Suenobu, K., Moriguchi, T., Kubo, K., Matsui, H. and Kuroyanagi, Y. (2004). Clinical Trials with Allogeneic Cultured Dermal Substitutes for the Treatment of Burns and Skin Ulcers (Regenerating Medical Millennium Project of the Ministry of Health, Labor and Welfare), Wound Repair Regen., 12: A12.
20. Klein, M.B., Engrav, L.H., Holmes, J.H., Freidrich, J.B., Costa, B.A. and Honari, S. (2005). Management of Facial Burns with a Collagen/ Glycosaminoglycan Skin Substitute-prospective Experience with 12 Consecutive Patients with Large, Deep Facial Burns, Burns, 31: 257-261.
21. Wainwright, D.J. (1995). Use of an Acellular Allograft Dermal Matrix (Alloderm) in the Management of Full Thickness Burns, Burns, 21: 243-248.
22. Wainwright, D., Nag, G. and Call, T. (1994). Normal Histological Features Persist in an Acellular Dermal Transplant Grafted in Full Thickness Burns, FASEB, 9-14.
23. Hansbrough, J.F., Dore, C. and Hansbrough, W.B. (1992). Clinical Trials of a Living Dermal Tissue Replacement Placed Beneath Meshed, Splitthickness Skin Grafts on Excised Burn Wounds, J. Burn Care Rehabil., 13: 519-529.
24. Rodeheaver, G.Y., Hartsell, M.L., Faulkner, B.C., Major, D.A. and Foresman, P.A. (1995). Influence of Biobrane Construction on Adherence, J. Burn Care Rehabil., 16: 321-323.
25. Purdue, G.F., Hunt, J.L., Gillespie, R.W., Hansbrough, J.F., Dominic, W.J., Robson, M.C., Smith, D.J., MacMillan, B.G., Waymac, J.P. and Herndon, D.N. (1987). Biosynthetic Skin Substitute versus Frozen Human Cadaver Allograft for Temporary Coverage of Excised Burn Wounds, J. Trauma, 27: 155-157.
26. Egan, W.C. and Clark, W.R. (1988). Toxic Shock Syndrome in a Burn Victim, Burns, 14: 135-138.
27. Lam, P.K., Chan, E.S., Liew, C.T., Law, C., Yen, S.C. and King, W.W. (2002). Combination of a New Composite Biocompatible Skin Graft on a Neoepidermis of Artificial Skin in an Animal Model, ANZ J. Surg., 72: 360-363.
28. Druecke, D., Lamme, E.N., Hermann, S., Pieper, J., May, P.S. and Steinau, H.U. (2004). Modulation of Scar Tissue Formation using Different Dermal Regeneration Templates in the Treatment of Experimental Full Thickness Wounds, Wound Repair Regen., 12: 518-527.
29. Lee, S.B., Kim, Y.H., Chong, M.S., Hong, S.H. and Lee, Y.M. (2005). Study of Gelatin-containing Artificial Skin V: Fabrication of Gelatin Scaffolds using a Salt-leaching Method, Biomaterials, 26: 18961-18968.
30. Middlekoop, E., de Vries, H.J., Ruuls, L., Everts, V., Wildevuur, C.H. and Westerhof, W. (1995). Adherance, Proliferation and Collagen Turnover by Human Fibroblasts Seeded into Different Types of Collagen Sponges, Cell Tissue Res., 280: 447-453.
31. Hansbrough, J. (1997). Dermagraft TC (Trancyte) for Partial-thickness Burns: A Clinical Evaluation, J. Burn Care Rehabil., 18: S25-28.
32. Pape, S.A. and Byrne, P.O. (2000). Safety and Efficacy of Transcyte for the Treatment of Partial-thickness Burns, J. Burn Care Rehabil., 21: 390.
33. Noordenbos, J., Dore, C. and Hansbrogh, J.F. (1999), Safety and Efficacy of TransCyte for the Treatment of Partial-thickness Burns, J. Burn Care Rehabil., 20: 275-281.
34. Hansbrough, J.F., Cooper, M.L. and Chohen, R. (1992). Evaluation of a Biodegradable Matrix Containing Cultured Human Fibroblasts as a Dermal Replacement Beneath Meshed Skin Grafts on Athymic Mice, Surgery, 111: 438-446.
35. Hansbrough, J.F., Morgan, J., Greenleaf, G. and Underwood, J. (1994). Development of a Temporary Living Skin Replacement Composed of Human Neonatal Fibroblasts Cultured in Biobrane, A Synthetic Dressing Material, Surgery, 115: 633-644.
36. Cooper, M.L., Hansbrough, J.F., Speilvogel, R.L., Cohen, R., Bartel, R.L. and Naughton, G. (1991). In vivo Optimization of a Living Dermal Substitute Employing Cultured Human Fibroblasts on a Biodegradable Polyglycolic Acid or Polyglactin Mesh, Biomaterials, 12: 243-248.
37. Naughton, G., Mansbridge, J. and Gentzkow, G. (1997). A Metabolically Active Human Dermal Replacement for the Treatment of Diabetic Foot Ulcers, Artif. Organs, 21: 1203-1210.
38. Allenet, B., Paree, F. and Lebrun, T. (2000). Cost-effectiveness Modeling of Dermagraft for the Treatment of Diabetic Foot Ulcers in the French Context, Diabetes Metab., 26: 125-132.
39. Hansbrough, J.F., Dore, C. and Hansbrough, W.B. (1992). Clinical Trials of a Living Dermal Tissue Replacement Placed Beneath Meshed, Split-thickness Skin Grafts on Excised Burn Wounds, J. Burn Care Rehabil., 13: 519-529.
40. Huang, Y.C., Wang, T.W., Sun, J.S. and Lin, F.H. (2005). Epidermal Morphogenesis in an in-vivo Model using Fibroblasts-embedded Collagen Scaffold, J. Biomed. Sci., 12: 855-867.
41. Kuroyanagi, Y., Kubo, K. and Matsui, H. (2004). Establishment of Banking System for Allogeneic Cultured Dermal Substitute, Artif. Organs, 28: 13-21.
42. Fujimori, Y., Ueda, K., Omiya Y., Kubo, K., Matsui, H. and Kuroyanagi, Y. (2004). Treatment with Autologous Cultured Dermal Substitutes (CDS) for Burn Scar Contracture in Children, Wound Repair Regen., 12: A11.
43. Mitrani, E., Nadel, G., Hasson, E., Harrari, E. and Shimoni, Y. (2005). Epithelial Mesenchymal Interactions Allow for Epidermal Cells to Display an in vivo like Phenotype in vitro, Differentiation, 73: 79-87.
44. Sawicki, G., Marcoux, Y., Sarkhosh, K., Tredget, E.E. and Ghahary, A. (2005). Interaction of Keratinocytes and Fibroblasts Modulates the Expression of Matrix Metalloproteinases -2 and -9 and their Inhibitors, Mol. Cell Biochem., 269: 209-216.
45. Greenberg, S., Margulis, A. and Garlick, J.A. (2005). In vivo Transplantation of Engineered Human Skin, Methods Mol. Biol., 289: 425-430.
46. Nanchahal, J., Dover, R. and Otto, W.R. (2002). Allogeneic Skin Substitutes Applied to Burns Patients, Burns, 28: 254-257.
47. Badiavas, E.V., Paquette, D., Carson, P. and Falanga, V. (2002). Human Chronic Wounds Treated with Bioengineered Skin: Histologic Evidence of Host-graft Interactions, J. Am. Acad. Dermatol., 46: 524-530.
48. Brem, H., Balledux, J., Sukkarieh, T., Carson, P. and Falanga, V. (2001). Healing of Venous Ulcers of Long Duration with a Bilayered Living Skin Substitute: Results from a General Surgery and Dermatology Department, Dermatol. Surg., 27: 915 -919.
49. Tremblay, P.L., Hudon, V., Berthod, F., Germain, L. and Auger, F.A. (2005). Inosculation of Tissue-engineered Capillaries with the Host's Vasculature in a Reconstructed Skin Transplanted on Mice, Am. J. Transplant., 5: 1002-1010.
50. Uccioli, L. (2003). A Clinical Investigation on the Characteristics and Outcomes of Treating Chronic Lower Extremity Wounds using the Tissue Tech Autograft System, Int. J. Low Extrem. Wounds, 2: 140-151.
51. Chan, E.S., Lam, P.K., Liew, C.T., Lau, H.C., Yen, R.S. and King, W.W. (2001). A New Technique to Resurface Wounds with Composite Biocompatible Epidermal Graft and Artificial Skin, J. Trauma, 50: 358-362.
52. Waymack, P., Duff, R.G. and Sabolinski, M. (2000). The Effect of a Tissue Engineered Bilayered Living Skin Analog, Over Meshed Split-thickness Autografts on the Healing of Excised Burn Wounds, The Apligraft Burn Study Group, Burns, 26: 609-619.
53. Phillips, T.J., Bhawan, J., Leigh, I.M., Baum, H.J. and Gilchrest, B.A. (1990). Cultured Epidermal Autografts and Allografts: A Study of Differentiation and Allograft Survival, J. Am. Acad. Dermatol., 23: 189-198.
54. Supp, D.M., Wilson-Landy, K. and Boyce, S.T. (2002). Human Dermal Microvascular Endothelial Cells form Vascular Analogs in Cultured Skin Substitutes after Agrafting to Athymic Mice, FASEB J., 16: 797-804.
55. Sahota, P.S., Burn, J.L., Heaton, M., Freelander, E., Suvurna, S.K., Brown N.J. and Mac Neil, S. (2003). Development of a Reconstructed Human Skin Model for Angiogenesis, Wound Repair Regen., 11: 275-284.
56. Swope, V.B., Supp, A.P., Cornelius, J.R., Babcock, G.F. and Boyce, S.T. (1997). Regulation of Pigmentation in Cultured Skin Substitutes by Cytometric Sorting of Melanocytes and Keratinocytes, J. Investigative Dermat., 109: 289-295.
57. Morgan, J.R., Barrandon, Y., Green, H. and Mulligan, R.C. (1987). Expression of an Exogenous Growth Hormone Gene in Transplantable Human Epidermal Cells, Science, 237: 1476-1479.
58. Supp, D.M., Supp, A.P., Bell, S.M. and Boyce, S.T. (2000). Enhanced Vascularization of Cultured Skin Substitutes Genetically Modified to Overexpress Vascular Endothelial Growth Factor, J. Invest. Dermatol., 114: 5-13.
59. Supp, D.M. and Boyce, S.T. (2002). Overexpression of Vascular Endothelial Growth Factor Accelerates Early Vascularization and Improves Healing of Genetically Modified Cultured Skin Substitutes, J. Burn Care Rehabil., 23: 10-20.
60. Fenjves, E.S., Gordon, D.A. and Pershing, L.K. (1989). Systematic Distribution of Apoliproprotein E Secreted by Grafts of Epidermal Keratinocytes: Implications for Epidermal Function and Gene Therapy, Proc. Natl. Acad. Sci. USA, 86: 8803-8807.
61. Fenjves, E.S., Smith, J. and Zaradic, S. (1994). Systemic Delivery of Secreted Protein by Grafts of Epidermal Keratinocytes: Prospects for Keratinocyte Gene Therapy, Hum. Gene Ther., 5: 1241-1248.
62. Vogt, P.M., Thompson, S. and Andree, C. (1994). Genetically Modified Keratinocytes Transplanted to Wounds Reconstitute the Epidermis, Proc. Natl. Acad. Sci. USA, 91: 9307-9311.
63. Jensen, U.B., Jensen, T.G. and Jensen, P.K. (1994). Gene Transfer into Cultured Human Epidermis and its Transplantation onto Immunodeficient Mice: An Experimental Model for Somatic Gene Therapy, J. Invest. Dermatol., 103: 391-394.
64. Suman, O.E., Thomas, S.J., Wilkins, J.P., Mlcak, R.P. and Herndon, D.N. (2003). Effect of Exogenous Growth Hormone and Exercise on Lean Muscle Mass and Muscle Function in Children with Burns, J. Appl. Physiol., 94: 2273-2281.
65. Przkora, R., Herndon, D.N., Suman, O.E., Jeschke, M.G., Meyer, W.J., Chinkes, D.L., Mlcak, R.P., Huang, T. and Barrow, R.E. (2006). Beneficial Effects of Extended Growth Hormone Treatment after Hospital Discharge in Pediatric Burn Patients, Ann. Surg., 243: 796-801.
66. Robson, M.C. and Smith, P.D. (2001). Topical Use of Growth Factors to Enhance Healing, In: Falanga, V. (ed.), Cutaneous Wound Healing, 1st edn, pp. 379-398, Informa Health care,London.
67. Lynch, S.E., Nixon, J.C., Colvin, R.B. and Antoniades, H.N. (1987). Role of Platelet-derived Growth Factor in Wound Healing: Synergistic Effects with Other Growth Factors, Proc. Natl. Acad. Sci. USA, 84 (21): 7696-7700.
68. Noguchi, A., Furuno, T., Kawaura, C. and Nakanishi, M. (1998). Membrane Fusion Plays an Important Role in Gene Transfection Mediated by Cationic Liposomes, FEBS, 433 (1-2): 169-173.
69. Miller, C.R., Bondurant, B. and McLean, S.D. (1998). Liposome-cell Interactions in vitro: Effect of Liposome Surface Charge on the Binding and Endocytosis of Conventional and Sterically Stabilized Liposomes, Biochem., 37(37): 12875-12883.
70. Williams, R.S., Johnston, S.A. and Riedy, M. (1991). Introduction of Foreign Genes into Tissues of Living Mice by DNA-coated Microprojectiles, Proc. Natl. Acad. Sci. USA, 88(7): 2726-2730.
71. Felgner, P.L. and Ringold, G.M. (1989). Cationic Liposome-mediated Transfection, Nature, 337(6205): 387-388.
72. Sprugel, K.H., McPherson, J.M., Clowes, A.W. and Ross, R. (1987). Effects of Growth Factors in vivo. I. Cell Ingrowth into Porous Subcutaneous Chambers, Am. J. Pathol., 129(3): 601-13.
73. Gossen, M. and Bujard, H. (1992). Tight Control of Gene Expression in Mammalian Cells by Tetracycline-responsive Promoters, Proc. Natl. Acad. Sci. USA, 89(12): 5547-5551.
74. Chandler, L.A., Gu, D.L. and Ma, C. (2000). Matrix-enabled Gene Transfer for Cutaneous Wound Repair, Wound Repair Regen., 8(6): 473-479.
75. Andreadis, S.T. (2007). Gene-modified Tissue-engineered Skin: The Next Generation of Skin Substitutes, Adv. Biochem. Eng. Biotechnol., 103: 241-274.